Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients

  • Hee Jeong Lee,
  • Haekyung Lee,
  • Song Hee Oh,
  • Joonbyung Park,
  • Suyeon Park,
  • Jin Seok Jeon,
  • HyunJin Noh,
  • Dong Cheol Han,
  • Soon Hyo Kwon

There are errors in Table 1. There are multiple incorrect abbreviations in the first column. Please see the corrected Table 1 here.

thumbnail
Download:
Table 1. Baseline characteristics of CKD stage 3–4, CKD stage 5-ESRD, and non-CKD groups.

https://doi.org/10.1371/journal.pone.0207561.t001

Reference

  1. 1. Lee HJ, Lee H, Oh SH, Park J, Park S, Jeon JS, et al. (2018) Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. PLoS ONE 13(9): e0203878. https://doi.org/10.1371/journal.pone.0203878 pmid:30212538

Citation: Lee HJ, Lee H, Oh SH, Park J, Park S, Jeon JS, et al. (2018) Correction: Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. PLoS ONE 13(11): e0207561. https://doi.org/10.1371/journal.pone.0207561

Published: November 12, 2018

Copyright: © 2018 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.